(Press-News.org) **Note: the release below is from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, 15-18 April). Please credit the conference if you use this story**
Did the recent mpox (formerly known as monkeypox) outbreak end because of “network immunity”? That’s the theory being put forward by Belgian researchers at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15-18 April).
2022 saw a global outbreak of mpox, a viral infection that had not previously been documented as having sustained person-to-person transmission outside of Africa. There were more than 85,000 cases worldwide, with men who have sex with men at highest risk.
Cases rose rapidly from May 2022, before starting to decline a few months later. The reasons the outbreak waned are unclear.
Researcher Dr Christophe Van Dijck, of the Institute of Tropical Medicine, Antwerp, Belgium, says: “The rapid rise in cases in May 2022 was likely caused by efficient viral transmission during sexual contact between individuals with high partner turnover in a dense and geographically extended sexual network.
“Insufficient knowledge of the disease as well as asymptomatic and pre-symptomatic transmission may have enhanced disease spreading. “
The subsequent decline in the epidemic after July 2022 remains insufficiently explained. Possible explanations include improved awareness and behavioural change in the population at risk and acquisition of vaccination- or infection-induced immunity.
“However, in most countries including Belgium, the decline in mpox cases had already started before a substantial proportion of the population at risk had been vaccinated.”
Thus, Dr Van Dijck and colleagues hypothesised that the epidemic waned due to a change in the behaviour of the population at risk.
To find out more, they used two sets of data collected at the Institute of Tropical Medicine in 2022. All participants provided informed consent.
The first set of data was from a questionnaire filled in at diagnosis by individuals with mpox.
Among the 155 individuals with mpox, 95.5% were gay and bisexual men who have sex with men (GBMSM) and the median number of sexual partners in the previous three weeks was two.
Individuals diagnosed with mpox at the beginning of the epidemic reported more partners than those later in the epidemic (decline of 0.86 partners per week).
The second set of data was from a questionnaire filled in by men who were attending a clinic at the Institute for pre-exposure prophylaxis (PrEP, a drug that reduces the risk of getting HIV).
For the purposes of the analysis the PrEP users were divided into two groups, core PrEP-users (those with a history of syphilis infection) and non-core PrEP-users (no history of syphilis). A history of syphilis was used as a proxy for more risky sexual behaviour in the past: a person who had syphilis is probably more centrally located in the sexual network than someone who never had syphilis.
Among 1,322 PrEP-users, 99.6% were GBMSM, of whom 55.9% visited the clinic repeatedly in 2022. At first visit, the median number of sexual partners in the previous three months was five. Core-group PrEP-users reported consistently more partners than non-core-group PrEP-users.
The number of partners in both the core and non-core-groups increased throughout 2022.
Dr Van Dijck says: “The decline in number of partners reported by individuals diagnosed with mpox towards the end of the epidemic suggests a change in behaviour of the population at risk. However, this was not corroborated by data from the PrEP population, where the overall number of sexual partners increased over time.
“Therefore, we propose an alternative hypothesis: core members of the sexual network were infected with mpox first, peripheral members later. Infection-induced immunity of the individuals at the core of the sexual network generated ‘network immunity’ which halted the epidemic.
“We are currently working on serological and modelling studies to establish whether this hypothesis is true.
“In the meantime, we need to be aware that future mpox outbreaks may occur if the ‘network immunity’ is disturbed, for example by waning immunity of infected or vaccinated persons or when previously uninfected, peripheral members of the sexual network become more sexually active.”
Dr Christophe Van Dijck, Institute of Tropical Medicine Antwerp, Antwerp, Belgium. T) +32 3 345 58 65 E) cvandijck@itg.be
Alternative contact: Tony Kirby in the ECCMID Media Centre. T) +44 7834 385827 E) tony@tonykirby.com
Notes to editors:
The authors declare no conflicts of interest.
This press release is based on oral presentation MMK0602 at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) annual meeting. The material has been peer reviewed by the congress selection committee. There is no full paper at this stage and, because this is an oral presentation, there isn’t a poster.
END
Why did the mpox (monkeypox) epidemic wane? Belgian researchers propose theory
2023-04-14
ELSE PRESS RELEASES FROM THIS DATE:
The Lancet Public Health: Hearing aids may protect against a higher risk of dementia associated with hearing loss, study suggests
2023-04-14
Peer-reviewed / Observational study / People
The Lancet Public Health: Hearing aids may protect against a higher risk of dementia associated with hearing loss, study suggests
Study of 437,704 people suggests those experiencing hearing loss and not using hearing aids may have a higher risk of dementia than people without hearing loss. Those using hearing aids did not appear to be at an increased risk of dementia.
After adjusting for other factors, study analysis suggests a 1.7% risk of dementia in people with hearing loss who are not using hearing aids, compared to 1.2% among those without hearing loss ...
One of first studies to assess new bivalent Covid-19 booster vaccine shows it is highly effective in reducing deaths and hospitalizations
2023-04-14
*Note: this is a joint press release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and The Lancet Infectious Diseases. Please credit both the congress and the journal in your stories*
Since September, 2022, bivalent mRNA vaccines – which contain elements from both the original wild type COVID strain and an updated component from the omicron strain – have replaced older style monovalent boosters in the USA, Israel, and other countries. These vaccines were designed to help improve vaccine-induced immunity against the omicron variant and subsequent subvariants.
A new study published in The Lancet Infectious Diseases and ...
A $1 million boost to UT’s venture culture
2023-04-14
Adding fuel to The University of Texas at Austin’s startup engine, alumnus William “Billy” Freed, BBA ’81, and his family have given $1 million to the Herb Kelleher Entrepreneurship Center in the McCombs School of Business.
The gift establishes the Freed Family Entrepreneurship Excellence Fund and endows the Freed Family Pitch Competition, previously called DisrupTexas. Freed’s wife Cheryl, BA ’82, JD ’84; sons Tyler, BS ’17, and Russell, BBA ’21; and daughter-in-law Leslie Lugrin Freed, BS ’17, ...
Data can now be processed at the speed of light!
2023-04-14
How can Marvel movie character Ant-Man produce such strong energy out of his small body? The secret lies in the “transistors” on his suit that amplify weak signals for processing. Transistors that amplify electrical signals in the conventional way lose heat energy and limit the speed of signal transfer, which degrades performance. What if it were possible to overcome such limitation and make a high-performance suit that is light and small but without loss of heat energy?
A POSTECH team of Professor Kyoung-Duck Park and Yeonjeong Koo from the Department of Physics and a team from ...
Disrupted rhythms of rest and wakefulness contribute to worse symptoms in schizophrenia patients
2023-04-14
PITTSBURGH, April 13, 2023 – In a paper published today in Molecular Psychiatry, a team of scientists from the University of Pittsburgh in collaboration with researchers in Italy described shared patterns of sleep disturbances and irregularities in daily rhythms of rest and activity across patients with schizophrenia spectrum disorder, or SSD.
By using wrist monitors that measured activity and rest as proxies of wakefulness and sleep, researchers found that individuals with SSD who resided in psychiatric hospitals and those who manage their condition in outpatient settings had erratic sleep patterns, dysregulated transitions between sleep ...
How AI and a mobile phone app could help you quit smoking
2023-04-14
A stop smoking mobile app that senses where and when you might be triggered to light up could help people quit – according to University of East Anglia research.
Quit Sense is the world’s first Artificial Intelligence (AI) stop smoking app which detects when people are entering a location they used to smoke in. It then provides support to help manage people’s specific smoking triggers in that location.
Funding for the Quit Sense app has come from the National Institute for Health and Care Research (NIHR) and the Medical Research Council.
A study published today shows how the new ...
Nurse sounds a warning on hearing loss for COVID-19 patients
2023-04-14
A University of South Australia nursing lecturer has used her own COVID-19 experience to inform research into a little-known side effect of the virus – sudden deafness.
Kim Gibson, a registered nurse with a clinical background in neonatal intensive care, has documented her experience with sudden sensorineural hearing loss (SSNHL) five weeks after testing positive to COVID-19. She was fully vaccinated.
Her findings and recommendations are published in the latest edition of the British Medical Journal Case Reports.
Gibson developed acute hearing loss in one ear, along with ...
Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye
2023-04-14
SINGAPORE, 14 April 2023 – A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting these into experimental models of damaged retinas has resulted in significant vision recovery. This finding, by scientists at Duke-NUS Medical School, the Singapore Eye Research Institute and the Karolinska Institute in Sweden, marks a first step towards potentially restoring vision in eye diseases characterised by photoreceptor loss.
“Our laboratory has developed a novel method that enables the production of photoreceptor ...
IOP Publishing celebrates World Quantum Day with the announcement of a special quantum collection and the winners of two prestigious quantum awards
2023-04-14
In celebration of World Quantum Day (14th April), IOP Publishing (IOPP) is launching a special collection of its most popular, cutting-edge quantum research published in the last two years.
The IOPP quantum collection is openly available for anyone to read and showcases world-class quantum research published in the academic journals Materials for Quantum Technology, Quantum Science and Technology, New Journal of Physics and Reports on Progress in Physics. The special collection will also include unique perspectives from women in quantum and their contributions to this popular field.
Quantum research and technology is evolving ...
Toppan and Hokkaido University launch Comprehensive Dementia Research Unit
2023-04-14
Tokyo – April 13, 2023 – Toppan (TYO: 7911), a global leader in communication, security, packaging, décor materials, and electronics solutions, and Hokkaido University have launched the “Comprehensive Dementia Research Unit,” an industry creation section that will collaborate with the Hokkaido University Collaborative Project Center’s Cognitive Science Research Center, which conducts comprehensive research on diagnosis technologies for dementia.
Fusing Toppan’s Digital ICA™1 technology for high-sensitivity ...